Table 3. Multivariate Analysis of predictors of response/remission at Week 14¥.
| Variable | OR | 95% CI` | p-value |
|---|---|---|---|
| Male | 0.74 | 0.25-2.12 | .57 |
| Active Smoker | 0.38 | 0.10-1.51 | .17 |
| Crohn's Disease | 0.69 | 0.16-2.89 | .61 |
| Perianal Disease | 0.32 | 0.08-1.26 | .10 |
| Number of prior anti-TNFs | 0.59 | 0.31-1.12 | .10 |
| Prednisone at induction | 0.34 | 0.10-1.18 | .08 |
| IMM at Induction | 0.56 | 0.19-1.66 | .30 |
| CRP > 8.0mg/L at Induction | 0.33 | 0.11-0.96 | .04 |
¥
Week 14 response and remission was combined as a composite end point to classify patients as either week 14 responders or non-responders. IMM-immunomodulator.